Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05695924 · ClinicalTrials.gov registry record · NA
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
A NA study of Lymphedema and Edema, sponsored by Fibralign Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05695924 is a NA study of Lymphedema and Edema that is actively recruiting participants, run by Fibralign Corporation. The registered enrollment target is 60 participants, below the 9,298-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05695924, a NA study of Lymphedema and Edema, is actively recruiting participants, sponsored by Fibralign Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
Conditions Studied
Interventions
- DEVICE BioBridge® Collagen Matrix
- PROCEDURE Vascularized Lymph Node Transfer (VLNT)
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05695924
The ClinicalTrials.gov registry entry for NCT05695924 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,298-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The listed sponsor is Fibralign Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lymphedema appearing as the primary indexed condition, and to 2 interventions - of which BioBridge® Collagen Matrix is the first listed.
NCT05695924 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05695924 about?
NCT05695924 is a clinical study titled "Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)". To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
What is the current status of trial NCT05695924?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-11-01. Estimated completion is 2025-12-01.
What conditions does trial NCT05695924 study?
This clinical trial studies the following conditions: Lymphedema, Edema.
What interventions are being tested in trial NCT05695924?
The interventions under investigation include: BioBridge® Collagen Matrix (DEVICE), Vascularized Lymph Node Transfer (VLNT) (PROCEDURE).
Who is sponsoring clinical trial NCT05695924?
This trial is sponsored by Fibralign Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05695924 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.